Masso Torrence Wealth Management Inc. Abb Vie Inc. Transaction History
Masso Torrence Wealth Management Inc.
- $178 Million
- Q4 2024
A detailed history of Masso Torrence Wealth Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Masso Torrence Wealth Management Inc. holds 9,235 shares of ABBV stock, worth $1.93 Million. This represents 0.92% of its overall portfolio holdings.
Number of Shares
9,235
Previous 9,796
5.73%
Holding current value
$1.93 Million
Previous $1.93 Million
15.15%
% of portfolio
0.92%
Previous 1.09%
Shares
13 transactions
Others Institutions Holding ABBV
# of Institutions
4,116Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$36.3 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$28.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$16.7 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.8 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.32 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $370B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...